Pericardial  ||| S:0 E:12 ||| JJ
tamponade  ||| S:12 E:22 ||| NN
in  ||| S:22 E:25 ||| IN
a  ||| S:25 E:27 ||| DT
patient  ||| S:27 E:35 ||| NN
with  ||| S:35 E:40 ||| IN
polymyalgia  ||| S:40 E:52 ||| JJ
rheumatica  ||| S:52 E:63 ||| NN
We  ||| S:63 E:66 ||| PRP
report  ||| S:66 E:73 ||| VBP
a  ||| S:73 E:75 ||| DT
patient  ||| S:75 E:83 ||| NN
who  ||| S:83 E:87 ||| WP
developed  ||| S:87 E:97 ||| VBD
pericarditis  ||| S:97 E:110 ||| JJ
and  ||| S:110 E:114 ||| CC
pericardial  ||| S:114 E:126 ||| JJ
tamponade  ||| S:126 E:136 ||| JJ
coinciding  ||| S:136 E:147 ||| NN
with  ||| S:147 E:152 ||| IN
polymyalgia  ||| S:152 E:164 ||| JJ
rheumatica  ||| S:164 E:175 ||| JJ
onset ||| S:175 E:180 ||| NN
.  ||| S:180 E:182 ||| .
Our  ||| S:182 E:186 ||| PRP$
patient  ||| S:186 E:194 ||| NN
did  ||| S:194 E:198 ||| VBD
not  ||| S:198 E:202 ||| RB
show  ||| S:202 E:207 ||| VB
any  ||| S:207 E:211 ||| DT
clinical  ||| S:211 E:220 ||| JJ
sign  ||| S:220 E:225 ||| NN
of  ||| S:225 E:228 ||| IN
vasculitis ||| S:228 E:238 ||| NNS
;  ||| S:238 E:240 ||| :
temporal  ||| S:240 E:249 ||| JJ
artery  ||| S:249 E:256 ||| NN
biopsies  ||| S:256 E:265 ||| NNS
were  ||| S:265 E:270 ||| VBD
negative  ||| S:270 E:279 ||| JJ
for  ||| S:279 E:283 ||| IN
giant  ||| S:283 E:289 ||| JJ
cell  ||| S:289 E:294 ||| NN
arteritis ||| S:294 E:303 ||| NN
.  ||| S:303 E:305 ||| .
Pericardial  ||| S:305 E:317 ||| JJ
biopsy  ||| S:317 E:324 ||| NN
in  ||| S:324 E:327 ||| IN
our  ||| S:327 E:331 ||| PRP$
case  ||| S:331 E:336 ||| NN
shows  ||| S:336 E:342 ||| VBZ
inflammatory  ||| S:342 E:355 ||| JJ
perivascular  ||| S:355 E:368 ||| JJ
lymphocytary  ||| S:368 E:381 ||| NNS
infiltrates  ||| S:381 E:393 ||| VBP
thus  ||| S:393 E:398 ||| RB
we  ||| S:398 E:401 ||| PRP
believe  ||| S:401 E:409 ||| VBP
pericardial  ||| S:409 E:421 ||| JJ
effusion  ||| S:421 E:430 ||| NN
has  ||| S:430 E:434 ||| VBZ
an  ||| S:434 E:437 ||| DT
inflammatory-immunologic  ||| S:437 E:462 ||| JJ
origin ||| S:462 E:468 ||| NN
.  ||| S:468 E:470 ||| .
Cardiac  ||| S:470 E:478 ||| JJ
manifestations  ||| S:478 E:493 ||| NNS
are  ||| S:493 E:497 ||| VBP
exceptional  ||| S:497 E:509 ||| VBN
in  ||| S:509 E:512 ||| IN
polymyalgia  ||| S:512 E:524 ||| JJ
rheumatica ||| S:524 E:534 ||| NN
,  ||| S:534 E:536 ||| ,
though  ||| S:536 E:543 ||| IN
it  ||| S:543 E:546 ||| PRP
should  ||| S:546 E:553 ||| MD
be  ||| S:553 E:556 ||| VB
considered  ||| S:556 E:567 ||| VBN
in  ||| S:567 E:570 ||| IN
the  ||| S:570 E:574 ||| DT
differential  ||| S:574 E:587 ||| JJ
diagnosis  ||| S:587 E:597 ||| NN
in  ||| S:597 E:600 ||| IN
patients  ||| S:600 E:609 ||| NNS
with  ||| S:609 E:614 ||| IN
pericarditis  ||| S:614 E:627 ||| NN
over  ||| S:627 E:632 ||| IN
50  ||| S:632 E:635 ||| CD
years ||| S:635 E:640 ||| NNS
.  ||| S:640 E:642 ||| .
The  ||| S:642 E:646 ||| DT
recognition  ||| S:646 E:658 ||| NN
of  ||| S:658 E:661 ||| IN
this  ||| S:661 E:666 ||| DT
uncommon  ||| S:666 E:675 ||| JJ
manifestation  ||| S:675 E:689 ||| NN
is  ||| S:689 E:692 ||| VBZ
very  ||| S:692 E:697 ||| RB
important  ||| S:697 E:707 ||| JJ
due  ||| S:707 E:711 ||| JJ
to  ||| S:711 E:714 ||| TO
the  ||| S:714 E:718 ||| DT
good  ||| S:718 E:723 ||| JJ
response  ||| S:723 E:732 ||| NN
to  ||| S:732 E:735 ||| TO
corticosteroid  ||| S:735 E:750 ||| VB
treatment ||| S:750 E:759 ||| NN
.  ||| S:759 E:761 ||| .
